Issued Patents All Time
Showing 1–20 of 20 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12253527 | Compositions and methods for treating age-related diabetes and related disorders | Sagar P. Bapat, Ye Zheng, Ronald M. Evans, Michael Downes, Annette Atkins | 2025-03-18 |
| 12213999 | Compositions and methods for treating type 1 and type 2 diabetes and related disorders | Ronald M. Evans, Eiji Yoshihara, Michael Downes, Annette Atkins | 2025-02-04 |
| 11981931 | Reprogramming progenitor compositions and methods of use thereof | Ronald M. Evans, Michael Downes, Yasuyuki Kida, Teruhisa Kawamura, Zong Wei +1 more | 2024-05-14 |
| 11760977 | Compositions and methods for organoid generation and disease modeling | Ronald M. Evans, Michael Downes, Annette Atkins, Eiji Yoshihara | 2023-09-19 |
| 11685901 | Compositions and methods for organoid generation and disease modeling | Ronald M. Evans, Michael Downes, Annette Atkins, Eiji Yoshihara | 2023-06-27 |
| 11542309 | Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose | Ronald M. Evans, Michael Downes, Annette Atkins, Sihao Liu | 2023-01-03 |
| 11440889 | Analogs of fexaramine and methods of making and using | Ronald M. Evans, Michael Downes, Annette Atkins, Sungsoon Fang, Jae Myoung Suh +3 more | 2022-09-13 |
| 11428697 | Compositions and methods for treating age-related diabetes and related disorders | Sagar P. Bapat, Ye Zheng, Ronald M. Evans, Michael Downes, Annette Atkins | 2022-08-30 |
| 11376264 | Use of bromodomain-containing protein 9 antagonists in combination with vitamin D receptor agonists in diabetes treatment | Ronald M. Evans, Michael Downes, Zong Wei, Annette Atkins | 2022-07-05 |
| 10920199 | Reprogramming progenitor compositions and methods of use therefore | Ronald M. Evans, Michael Downes, Yasuyuki Kida, Teruhisa Kawamura, Zong Wei +1 more | 2021-02-16 |
| 10912800 | Compositions and methods for treating type 1 and type 2 diabetes and related disorders | Ronald M. Evans, Eiji Yoshihara, Michael Downes, Annette Atkins | 2021-02-09 |
| 10815203 | Analogs of fexaramine and methods of making and using | Ronald M. Evans, Michael Downes, Annette Atkins, Sungsoon Fang, Jae Myoung Suh +3 more | 2020-10-27 |
| 10695404 | Treatment of steroid-induced hyperglycemia with fibroblast growth factor (FGF) 1 analogs | Ronald M. Evans, Michael Downes, Annette Atkins | 2020-06-30 |
| 10539572 | Compositions and methods for treating age-related diabetes and related disorders | Sagar P. Bapat, Ye Zheng, Ronald M. Evans, Michael Downes, Annette Atkins | 2020-01-21 |
| 10450277 | Analogs of fexaramine and methods of making and using | Ronald M. Evans, Michael Downes, Annette Atkins, Sungsoon Fang, Jae Myoung Suh +3 more | 2019-10-22 |
| 10301268 | Analogs of fexaramine and methods of making and using | Ronald M. Evans, Michael Downes, Annette Atkins, Sungsoon Fang, Jae Myoung Suh +3 more | 2019-05-28 |
| 9925241 | Mutated fibroblast growth factor (FGF) 1 and methods of use | Jae Myoung Suh, Michael Downes, Ronald M. Evans, Annette Atkins | 2018-03-27 |
| 9546379 | Compositions and methods for treating type 1 and type 2 diabetes and related disorders | Ronald M. Evans, Eiji Yoshihara, Michael Downes, Annette Atkins | 2017-01-17 |
| 9192601 | Methods for enhancing muscle performance and tone | Ronald M. Evans, Vihang A. Narkar, Reuben J. Shaw, Michael Downes | 2015-11-24 |
| 8962546 | Modulation of estrogen receptor-related receptor gamma (ERRγ) and uses therefor | Vihang A. Narkar, Michael Downes, Ronald M. Evans | 2015-02-24 |